Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Hard Copy Electronic The Pharmaceutical Industry 2008: Current and Future Trends and Strategic Issues Shaping Pharma Datamonitor, March 2008, Pages: 187   Description     Table of Contents     Companies Mentioned        Enquire before Buying    Send to a Friend   Today, pharma companies face growing competition from generics and me-too drugs, combined with increasingly tough P&R, a clamp down on healthcare spending, and the need to treat patients for longer due to the aging population. These factors threaten both current and future revenues prompting Pharma to adopt a range of corporate strategies to respond to the changing market dynamics. Scope - Review of key external factors impacting Pharma and shaping their strategies - Analysis of steps undertaken by pharma companies to achieve cost saving and improve efficiency - Assessment of corporate strategies employed by drug developers to generate new revenue growth Highlights of this title Fewer drugs are gaining FDA approval year-on-year, primarily due to increasing pressure the pharmaceutical industry is facing over drug safety, fueled by several recent high-profile drug withdrawals and black box warnings. Compounded with the recent expansion of the FDAs safety powers, this will have a negative impact on Pharmas profitability. The pharmaceutical industry is facing increasingly cost-conscious times, with a declining ROI and numerous blockbuster products facing imminent generic competition. This is exacerbated by the increasing cost of licensing and M&A deals, and a harshening P&R environment. A key trend in 2007 has been the vast number of job cuts across Big Pharma in an effort to cut costs, in response to disappointing financial results driven by patent expiries of key products and resulting generic erosion. Price pressure and low reimbursement rates, which are impacting company revenues, are set to continue in 2008. Key reasons to purchase this title - Identify the key trends that are impacting the industry in 2007, going forward in 2008 and beyond - Understand what strategic steps pharma companies are making to maintain their profitability by cutting costs - Gain insight into how Pharma are capturing new opportunities to sustain historic growth rates Customers who bought this item also bought Key Trends in European Patient Monitoring Systems Market The Pharmaceutical Industry 2008: Current and Future Trends and Strategic Issues Shaping Pharma Telecoms Market in Central and Eastern Europe 2007 Development Forecasts 2007-2010 Global Communications Power: Market Forecasts, Business Trends and Competitive Analysis, Eighth Edition Chinese Pharmaceutical Industry: Strategies, Trends and Opportunities Textile Outlook International - Business and Market Analysis for the Global Textile and Apparel Industries China Pharmaceutical Industry: Analysis and Market Trends The European Aftermarket: Companies, Sectors, Trends

		Top of page

All rights reserved. � Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster